EXHIBIT 4.6 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of March 23, 1999, is by and between Sepracor Inc., a Delaware corporation ("Sepracor"), and HemaSure Inc., a Delaware corporation (the...Registration Rights Agreement • April 1st, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Exhibit 10.31 FORM OF PURCHASE AGREEMENT HEMASURE INC. March 2, 2000 HEMASURE INC. PURCHASE AGREEMENT This Purchase Agreement (the "Agreement") is made as of the __ day of March, 2000 (the "Agreement Date"), by and between HemaSure Inc., a Delaware...Purchase Agreement • March 30th, 2000 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Exhibit 10.05 FORM OF WARRANT --------------- Warrant No. --- THIS WARRANT (AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN...Point Therapeutics Inc • May 15th, 2002 • Surgical & medical instruments & apparatus • Delaware
HEMASURE INC. andStockholder's Agreement • May 17th, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
EXHIBIT 4.7 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this "Agreement"), dated as of March 23, 1999 is by and between HEMASURE INC., a Delaware corporation ("HemaSure"), and SEPRACOR INC., a Delaware corporation (the "Holder"). W I T N E S S E T H:...Warrant Agreement • April 1st, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Exhibit 10.33 SETTLEMENT AGREEMENT 1. Parties HemaSure Inc., 140 Locke Drive, Marlborough, MA 01752-1146, USA ("HemaSure") and HemaSure AB, reg.no. 556307-7311, c/o Lagerlof & Leman, Box 5402, S-114 84 Stockholm, Sweden, hereinafter jointly referred...Settlement Agreement • March 31st, 1998 • Hemasure Inc • Surgical & medical instruments & apparatus
RECITALS:Agreement and Plan of Merger • December 18th, 2007 • Point Therapeutics Inc • Pharmaceutical preparations
Exhibit 4.3 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (the "Agreement"), dated as of September 15, 1998, by and between Sepracor Inc., a Delaware corporation ("Sepracor"), and HemaSure Inc., a Delaware corporation (the "Company")....Registration Rights Agreement • November 16th, 1998 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
EXHIBIT 10.33 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this "Agreement") is made this 23 day of March, 1999 by and between Hemasure Inc., a Delaware corporation (the "Company"), and Sepracor Inc., a Delaware corporation (the...Securities Purchase Agreement • April 1st, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
CLASS B COMMON STOCK PURCHASE WARRANT DARA BIOSCIENCES, INC.DARA BioSciences, Inc. • December 29th, 2010 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the one year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from DARA Bioscience, Inc., a Delaware corporation (the “Company”), up to shares (the “Warrant Shares”) of Common Stock.
COMMON STOCK PURCHASE WARRANT DARA BIOSCIENCES, INC.Common Stock Purchase Warrant • May 30th, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _______, 2014 (the “Initial Exercise Date”)1 and on or prior to the close of business on _________, 20192 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DARA Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 9th, 2012 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 6, 2012, between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
ContractSecurities Purchase Agreement • April 18th, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of _______, 2014 (the “Effective Date”), between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 30th, 2014 • DARA BioSciences, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 30, 2014 (the “Effective Date”), between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
HEMASURE INC.Registration Rights Agreement • March 31st, 1997 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
EXHIBIT 10.01 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (hereafter referred to as this "Agreement") is made by and between Point Therapeutics, Inc, a Delaware corporation, (the "Company") and Michael P. Duffy, Esq. (the...Employment Agreement • August 8th, 2002 • Point Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts
BETWEEN HEMASURE INC. ANDIntellectual Property Security Agreement • November 16th, 1998 • Hemasure Inc • Surgical & medical instruments & apparatus • Massachusetts
Exhibit 10.01 FIRST AMENDED EXECUTIVE EMPLOYMENT AGREEMENT This First Amended Executive Employment Agreement (hereafter referred to as this "Agreement") is made by and between Point Therapeutics, Inc, a Massachusetts corporation, (the "Company") and...Employment Agreement • May 15th, 2002 • Point Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts
COMMON STOCK PURCHASE WARRANT DARA BIOSCIENCES, INC.DARA BioSciences, Inc. • February 12th, 2014 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February__________, 2014 (the “Initial Exercise Date”) and on or prior to the close of business on February __________, 20191 (the “Termination Date”) but not thereafter, to subscribe for and purchase from DARA Bioscience, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Exhibit 10.33 INDEMNIFICATION AGREEMENT ------------------------- This Agreement is made as of the 13th day of July, 2000, by and between Ahlstrom Technical Specialties LLC, a Delaware limited liability company ("Ahlstrom"), and HemaSure Inc., a...Indemnification Agreement • August 11th, 2000 • Hemasure Inc • Surgical & medical instruments & apparatus • Delaware
Exhibit 10.16 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (hereafter referred to as this "Agreement") is made by and between Point Therapeutics, Inc, a Delaware corporation, (the "Company") and Barry Jones, Ph.D. (the...Executive Employment Agreement • March 31st, 2003 • Point Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts
EMPLOYMENT AGREEMENT --------------------Employment Agreement • November 14th, 2001 • HMSR Inc • Surgical & medical instruments & apparatus • Massachusetts
SUMMIT ROUNDTABLEConsulting Agreement • November 14th, 2001 • HMSR Inc • Surgical & medical instruments & apparatus
Mr. Richard A. Franco, Sr. Chief Executive Officer DARA BioSciences, Inc.DARA BioSciences, Inc. • September 14th, 2009 • Pharmaceutical preparations • Georgia
Exhibit 10.1 RESTRUCTURING AGREEMENT THIS RESTRUCTURING AGREEMENT (the "Agreement"), dated January 23, 1997, is made and entered into by and among HemaSure Inc., a Delaware corporation with its principle place of business at 140 Locke Drive,...Restructuring Agreement • February 27th, 1997 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
HEMASURE INC.Hemasure Inc • March 31st, 1997 • Surgical & medical instruments & apparatus • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 29th, 2010 • DARA BioSciences, Inc. • Pharmaceutical preparations • North Carolina
This Securities Purchase Agreement (this “Agreement”) is dated as of December 29, 2010, between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 10.37 TERMINATION AND RELEASE AGREEMENT This Agreement, effective the 5th day of March, 2001 (the "Effective Date"), by and between HemaSure Inc. ("HemaSure"), a Delaware corporation having a principal place of business at 140 Locke Drive,...Termination and Release Agreement • March 26th, 2001 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
ARTICLE I DEFINITIONSManufacturing and Supply Agreement • March 30th, 2000 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN HEMASURE INC. AND COBE LABORATORIES, INC.Exclusive Distribution Agreement • May 17th, 1999 • Hemasure Inc • Surgical & medical instruments & apparatus • New York
Exhibit 10.04 Execution Copy AMENDED AND RESTATED LICENSE AGREEMENT The License Agreement made and entered into as of May 7, 1997 ("the date of the original Agreement"), by and between Point Therapeutics, Inc. (formerly known as Immune Therapeutics,...License Agreement • May 15th, 2002 • Point Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 2nd, 2007 • Point Therapeutics Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 1, 2007, among Point Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 1st, 2004 • Point Therapeutics Inc • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 24, 2004, by and among Point Therapeutics, Inc., a Delaware corporation (the “Company”), and the investors signatory hereto (each a “Investor” and collectively, the “Investors”).
AGREEMENT AND PLAN OF MERGER by and amongAgreement and Plan of Merger • June 4th, 2015 • DARA BioSciences, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is dated as of June 3, 2015, by and among Midatech Pharma PLC, a public limited company organized under the laws of England and Wales (“Parent”), Merlin Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), Duke Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Secondary Merger Sub”), DARA BioSciences, Inc., a Delaware corporation (the “Company”), and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as representative of the Stockholders (as defined below) of the Company (the “Stockholder Representative”). Parent, Merger Sub, Secondary Merger Sub, the Company and the Stockholder Representative are referred to herein collectively as the “Parties.”
David J. Drutz, M.D. Chief Executive Officer DARA BioSciences, Inc.DARA BioSciences, Inc. • May 30th, 2014 • Pharmaceutical preparations • New York
